Commodore Capital Lp - Insider Trading & Ownership

Entity
Company
Location
444 Madison Avenue, 35 Th Floor, New York, NY
Summary
The estimated value of insider holdings of Commodore Capital Lp is at least $431M dollars as of January 12, 2024. Commodore Capital Lp is the 10%+ Owner of Ambrx Biopharma Inc. and owns shares of Ambrx Biopharma Cayman, Inc. stock worth about $330M. Commodore Capital Lp is the 10%+ Owner of Vera Therapeutics, Inc. and owns shares of Vera Therapeutics, Inc. (VERA) stock worth about $79.2M. Commodore Capital Lp is the 10%+ Owner of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $21.9M. Commodore Capital Lp is the 10%+ Owner of Satsuma Pharmaceuticals, Inc. and owns shares of Satsuma Pharmaceuticals, Inc. stock worth about $326K.
All Insider Reports
All Insider Reports

Ownership of Commodore Capital Lp

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AMAM Ambrx Biopharma Cayman, Inc. 10%+ Owner $330M Feb 23, 2023
VERA Vera Therapeutics, Inc. 10%+ Owner $79.2M -$18.9M -19.3% Jan 10, 2024
ELVN Enliven Therapeutics, Inc. 10%+ Owner $21.9M Feb 23, 2023
STSA Satsuma Pharmaceuticals, Inc. 10%+ Owner $326K Nov 14, 2022
VTGN Vistagen Therapeutics, Inc. 10%+ Owner Oct 4, 2023

Insider Transactions Reported by Commodore Capital Lp:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.